48
In band
Moving averages
SMA 200$0.74-51.91%
Company profile
Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. The company is headquartered in Princeton, New Jersey.
SectorHealthcare
IndustryBiotechnology
Market cap$7.73M
P/E ratioNone
EPS$-0.79
Beta1.996
Dividend yield0.00%
52-week high$1.76
52-week low$0.28
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
ACXP
Acurx Pharmaceuticals Inc
RSI 27
IMNN
Imunon Inc
RSI 36
SKYE
Skye Bioscience Inc
RSI 31
PHIO
Phio Pharmaceuticals Corp
RSI 37
KTTA
Pasithea Therapeutics Corp
RSI 34
BCDA
BioCardia Inc
RSI 38
RSI alerts for SNGX
An email when SNGX closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 17 October 2026 at 12:41 AM EDT